Skip to main content

IMMUTEP Ltd

IMMP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001506184

No open-market purchases or sales by IMMUTEP Ltd insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $692.0K in total; no superinvestor holds it.

Other share classesPRRUF

Q3 2024 vs. Q2 2024

How the institutions holding IMMUTEP Ltd changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of IMMP: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders28123−4
Shares2.41M839.1K1.93M+359.1K (+22.9%)
Value$4.84M$1.69M$4.26M+$1.11M (+35.1%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held IMMUTEP Ltd at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to IMMP in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.908,141$2.01M0.00%
HighTower Advisors, LLC7,201$16.0K0.00%
UBS Group AG1,849$4.09K0.00%
Principal Securities, Inc.52$1150.00%

Sold out (8)

Institutions that held IMMUTEP Ltd at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of IMMP in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Old Mission Capital LLC113,037$227.2K
Group One Trading, L.P.31,041$62.4K
BNP Paribas Arbitrage, SA27,300$54.9K
Simplex Trading, LLC23,490$47.0K
Virtu Financial LLC18,566$37.0K
Qube Research & Technologies Ltd499$1.00K
Ronald Blue Trust, Inc.353$822
Tower Research Capital LLC (TRC)83$167

Not filed for Q3 2024 yet (1)

Institutions that held IMMUTEP Ltd at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding IMMP in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.839,081$1.69M